Cardiologist - Heart Doctor: Julian Loh | National Heart Centre Singapore (NHCS)
Skip Ribbon Commands
Skip to main content
Menu
Clin Asst Prof Loh Xingyuan Julian Kenrick

Clin Asst Prof Loh Xingyuan Julian Kenrick

BA, MB BCh BAO (Hons) (Ireland), MRCP (Ireland), MRCP (UK), ASCeXAM (Testamur), GDip (Pall Med), FAMS (Cardiology)

Senior Consultant

National Heart Centre Singapore

Specialty: Cardiology

Clinical Interest: Heart Failure, Heart Transplant, Echocardiography

Clinical Appointments

  • Senior Consultant Department of Cardiology National Heart Centre SingaporeNational Heart Centre Singapore
  • Director of Coronary Care Unit National Heart Centre SingaporeNational Heart Centre Singapore
  • Senior Consultant NHCS Cardiology @ SKH Sengkang General HospitalSengkang General Hospital

Academic Appointments

  • Director, Cardiology Senior Residency Program SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme
  • Clinical Asst Professor

Profile

Clin Asst Prof Julian Kenrick Loh is a Senior Consultant with the Department of Cardiology and Director of the Coronary Care Unit at the National Heart Centre Singapore (NHCS). His sub-specialty interest is in Heart Failure and Echocardiography. 

He underwent fellowship training at the Royal Papworth Hospital, Cambridge, United Kingdom in Advanced Heart Failure, Critical Care Cardiology, Left ventricular assist device and heart transplant.

Clin Asst Prof Loh is actively involved in clinical education and is the Programme Director for the Cardiology Senior Residency. He was previously the SingHealth Internal Medicine Associate Program Director chairing the Admissions Committee and Programme Evaluation Committee. He currently remains Core Faculty with Internal Medicine and physician faculty with surgery-in-general residencies and also teaches in the local medical schools and polytechnics.

He is actively involved in clinical research and clinical trials. In addition to presenting his research at regional and international scientific meetings, he has also published his original research in international peer-reviewed publications.

Education

  • GDip (Pall Med), 2018
  • ASCeXAM (Testamur), 2017
  • MRCP (UK), 2011
  • MRCP (Ireland), 2011
  • BA, MB BCh BAO (Hons) (Ireland), 2008

Professional Appointments and Committee Memberships

  • Member, SingHealth Intensive Care Unit Committee
  • Cardiology Lead, Extracorporeal Membrane Oxygenation Committee        
  • Member, Singapore General Hospital Campus Code Blue Workgroup
  • Member, Campus-Wide Early Warning System Workgroup         
  • Member, Clinical Alarms Committee
  • Member, Heart Transplant and Mechanical Circulatory Support Committee
  • Member, Organ Donation Oversight Committee
  • Member, Singhealth Duke-NUS Medical Humanities Institute
  • Member, Council of Singhealth Ethics Network        
  • NHCS Clinical Lead, Singhealth Duke-NUS Supportive & Palliative Care Centre
  • Member, Faculty & Professional Development Executive Committee        
  • Member, Clinical Review Programme Committee 
  • Member, Quality Improvement Project Evaluation Committee
  • Member, National Heart Centre Singapore Fundraising Steering Committee
  • Heart Failure Society Singapore, Education Subcommittee
  • Center for Medical Ethics & Professionalism, Singapore Medical Association Faculty

Awards

  • National University Singapore Special recognition award (NUS MedACE) (2023)
  • Faculty Appreciation Award – Residency in Singhealth Excels (RISE) (2023)
  • Health Manpower Development Plan (HMDP) Fellowship (2023) 
  • SingHealth Health Quality Service Star Award, 2020
  • SingHealth Health Quality Service Bronze Award, 2019  
  • SingHealth Health Quality Service Gold Award, 2018  
  • SingHealth Outstanding Faculty Award, 2018
  • SingHealth Outstanding Faculty Award, 2017
  • SingHealth Health Quality Service Silver Award, 2016  
  • NUHS - Harvard Medical Jeopardy – Winner, Feb 2013
  • Intern Medal (Gold), St James Hospital, Republic of Ireland, 2009
  • Grand Rounds Presentation of the Year, Portiuncula Hospital “The Fiber Myth", 2008

Research Interests

Publications

  • SHS Neo, JYT Tan, DKL Sim, ESL Ng, JKX Loh, GM Yang, FEM Murtagh & YB Cheung. Validity and reliability of integrated palliative care outcome scale in asian heart failure patients. Palliative Medicine reports 2022 Vol 3.1: 287-295.
  • K Anbalakan, KM Chew, JK Loh, D Sim, SH Lai & LLY Teo. Contemporary reiew of heart transplant immunology and immunosuppressive therapy. Proceedings of Singapore Healthcare 2022. Volume 31: 1–8.
  • Myocarditis following COVID-19 Vaccination: A systematic review (October 2020 – October 2021). Heart Lung and Circulation. 2022-2. Lee ASY, Balakrishnan ID, Khoo CY, Ng CT, Loh JKX, Chan LL, Teo LLY, Sim DKL DOI: 10.1016/j.hlc.2022.02.002
  • Sacubitril/valsartan for heart failure in patients with complex adult congenital heart disease – Experience from a tertiary centre in Singapore. Yan L, Loh JK, Tan JL. International Journal of Cardiology Congenital Heart Disease 6 (2021) 100268 https://doi.org/10.1016/j.ijcchd.2021.100268
  • Predicting premature termination of exercise during BRUCE protocol stress echocardiography
    Loh JK, Amanullah MR, See CK, Tang HC, Gunasegaran K, Hamid N, Lau J, Lee CY, Ewe SH, Ding ZP, Sahlen A. Echocardiography 2021: 1-6. https://doi.org/10.1111/echo.15186
  • Beyond return of spontaneous circulation: update on post cardiac arrest management in the intensive care unit. Chia YW, Lim SL, Loh JK, Leong BSH, Ong MEH. Singapore Med J 2021; 62(8): 444-451
  • Plasma exchange and early thyroidectomy in thyroid storm requiring extracorporeal membrane oxygenation. Koh HL, Kaushik M, Loh JK & Chng CL. Endocrinology, Diabetes and Metabolism Case Reports 2019 Jul: 19-0051
  • Remote magnetic catheter navigation versus conventional ablation in atrial fibrillation ablation: Fluoroscopy reduction. Paul Chun Yih Lim, Joseph Jia Hong Toh, Julian Kenrick Xing Yuan Loh, Edward Chun Yi Lee, Daniel Thuan Tee Chong, Boon Yew Tan, Kah Leng Ho, Chi Keong Ching & Wee Siong Teo. Journal of Arrhythmia 2017 Jun;33(3):167-171
  • Coffee, Tea, Caffeine and risk of hypertension: The Singapore Chinese Health Study. Chei CL, Loh JK, Soh A, Yuan JM & Koh WP. European Journal of Nutrition 2018 June; 57 (4): 1333-1342
  • Empathy and Burnout - a study on residents from a Singaporean institution. Lee PT, Loh JK, Sng G, Tung J & Yeo KK. Singapore Medical Journal 2018 Jan; 59(1): 50–54
  • Venous Thromboprophylaxis in the acute medical setting – an audit of a tertiary university teaching hospital. OD Lyons, JK Loh, M Lim, D O’Riordan & B Silke. Irish Medical Journal 2013 Sep; 106(8):235-238
  • Sternoclavicular joint septic arthritis and osteomyelitis caused by Aggregatibacter aphrophilus. JK Loh, D O’Shea, K O’Connell, B Crowley & CJ Bergin. Quarterly Journal of Medicine 2012. (QJM 2012; doi: 10.1093/qjmed/hcr272)
  • Triple Vessel Mesenteric Ischaemia presenting with chronic gastric ulceration: An unusual case report. JK Loh, F O’Kelly, KT Lim, W Shields, N Ravi, NPW Keeling, JV Reynolds. Irish Journal of Medical Science 2011 Volume 180, Number 2 (2011), 537-540, DOI: 10.1007/s11845-011-0672

Research Trials

 
Site lead investigator:
  • Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) Trial
  • Targeted Temperature Management after out-of-hospital cardiac arrest (TTM2) Trial
  • Evaluation of the Efficacy and Safety of Antibiotic Therapeutic Drug Monitoring (TDM) in Patients with Difficult-to-Treat Gram-Negative Bacterial (DT-GNB) Infections
  • Early Neuroprognostication For Out-of-hospital caRdiaC arrEst (ENFORCE) study

Co-investigator:
  • A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation (LIBREXIA-AF)
  • MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)
  • A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction

  • Previous clinical trials: VICTORIA, PARAGON-HF, PARADISE MI, EMPEROR-Preserved and AFFIRM-AHF.